Mico BioMed Co. Ltd. (214610) — Financial Flexibility Index
Mico BioMed Co. Ltd. (214610) has a Financial Flexibility Index of -1.03x as of September 2025. Free cash flow of ₩-8.13 Billion (operating CF ₩-8.13 Billion minus capex ₩0.00) represents -1% of total liabilities (₩7.88 Billion). Check Mico BioMed Co. Ltd. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mico BioMed Co. Ltd. Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Mico BioMed Co. Ltd. across 9 annual periods. See Mico BioMed Co. Ltd. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mico BioMed Co. Ltd. (2016–2024)
Year-by-year free cash flow to debt coverage for Mico BioMed Co. Ltd.. For the full company profile including market capitalisation, see 214610 company net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.34x | ₩-9.71 Billion | ₩-10.70 Billion | ₩28.58 Billion | ▲ +20.5% |
| 2023 | -0.43x | ₩-10.68 Billion | ₩-11.36 Billion | ₩24.99 Billion | ▼ -37.4% |
| 2022 | -0.31x | ₩-12.38 Billion | ₩-14.01 Billion | ₩39.82 Billion | ▼ -96.6% |
| 2021 | -0.16x | ₩-5.76 Billion | ₩-8.60 Billion | ₩36.42 Billion | ▲ +81.6% |
| 2020 | -0.86x | ₩-12.92 Billion | ₩-18.68 Billion | ₩15.00 Billion | ▼ -127.4% |
| 2019 | -0.38x | ₩-9.10 Billion | ₩-10.43 Billion | ₩24.01 Billion | ▼ -41.7% |
| 2018 | -0.27x | ₩-4.93 Billion | ₩-6.79 Billion | ₩18.45 Billion | ▼ -43.0% |
| 2017 | -0.19x | ₩-2.43 Billion | ₩-2.89 Billion | ₩13.02 Billion | ▲ +72.1% |
| 2016 | -0.67x | ₩-3.79 Billion | ₩-3.99 Billion | ₩5.65 Billion | — |